HI
BLUE

HBK Investments’s bluebird bio BLUE Stock Holding History

HBK Investments’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-75,000
Closed -$2.07M – 174
2023
Q4 		$2.07M Buy
+75,000
New +$4.57M 0.01% 157
2018
Q1 		– Sell
-1,158
Closed -$2.67M – 977
2017
Q4 		$2.67M Buy
1,158
+1,027
+784% +$2.08M 0.02% 387
2017
Q3 		$233K Sell
131
-4,578
-97% -$6.4M ﹤0.01% 933
2017
Q2 		$6.41M Buy
+4,709
New +$5.68M 0.04% 210
2015
Q4 		– Sell
-198
Closed -$219K – 977
2015
Q3 		$219K Sell
198
-1,677
-89% -$3.06M ﹤0.01% 921
2015
Q2 		$4.09M Buy
+1,875
New +$3.82M 0.04% 257

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

HBK Investments's BLUE Position: Q1 2024 in Review

HBK Investments sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 75,000 shares — an estimated $2.07M sold.

HBK Investments first reported a position in BLUE in Q2 2015 and held it in 6 quarters. The position peaked at $6.41M in Q2 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • HBK Investments reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • HBK Investments sold 75,000 bluebird bio shares in Q1 2024, an estimated $2.07M.
  • HBK Investments first reported a position in bluebird bio in Q2 2015 and held it in 6 quarters.
  • HBK Investments's bluebird bio position peaked at $6.41M in Q2 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on HBK Investments's 13F filing for Q1 2024, filed 15 May 2024.